SCHEMBL31408362

SCHEMBL31408362

CC(=O)NCc1cc2cc(Cl)c(-c3cnc4[nH]ccc4c3)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 4/20 0.44
▸ METTL14 Q9HCE5 4/20 0.44
▸ PIK3C3 Q8NEB9 1/20 0.43
▸ CDK8 P49336 10/20 0.43
▸ MAP4K4 O95819 2/20 0.43
▸ CHEK2 O96017 2/20 0.43
▸ CDK1 P06493 2/20 0.43
▸ FES P07332 2/20 0.43
▸ ROS1 P08922 2/20 0.43
▸ FER P16591 2/20 0.43
▸ FLT4 P35916 2/20 0.43
▸ KDR P35968 2/20 0.43
▸ IRAK1 P51617 2/20 0.43
▸ ROCK1 Q13464 2/20 0.43
▸ PKN2 Q16513 2/20 0.43
▸ MARK2 Q7KZI7 2/20 0.43
▸ MINK1 Q8N4C8 2/20 0.43
▸ AURKB Q96GD4 2/20 0.43
▸ SLK Q9H2G2 2/20 0.43
▸ MKNK2 Q9HBH9 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31408351 0.83 SMN1; SMN2 (0.40) AURKBSMN1; SMN2
SCHEMBL31408571 0.82 SMN1; SMN2 (0.41) CDK8CCNCSMN1; SMN2
SCHEMBL31408611 0.82 SMN1; SMN2 (0.41) SMN1; SMN2
SCHEMBL31408594 0.82 SMN1; SMN2 (0.38) AURKBSMN1; SMN2
SCHEMBL31408586 0.82 SMN1; SMN2 (0.40) AURKBSMN1; SMN2
SCHEMBL31408238 0.82 SMN1; SMN2 (0.40) AURKBSMN1; SMN2
SCHEMBL31408448 0.81 RAB9A (0.38) SMN1; SMN2
SCHEMBL31408473 0.81 SMN1; SMN2 (0.37) ROCK1ROCK2SMN1; SMN2
SCHEMBL31408250 0.81 PRKAG1 (0.48) AURKBSYKSMN1; SMN2
SCHEMBL31408452 0.80 SMN1; SMN2 (0.44) CDK8ROCK2CCNCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback